BTMD biote Corp.

NASDAQ

$1.22

biote Corp. (BTMD) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.05 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -36.1% since its last earnings release on August 5, 2026.

biote Missed Consensus Estimates, Lowers Guidance

Wednesday, August 5, 2026 · 4:05 PM ET

3rd Quarter, Sep 2026

Monday · 4:05 PM ET

Earnings Whisper

-

vs ($0.05)

Rev est $43.99M

Volatility

Enter your expectations below to reveal the current volatility.

Trend Analysis

Expectation

Earnings

Price action

Signals

Score

Sentiment

Grade

Life Cycle

Call Analysis

Earnings-AVWAP $1.52

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About biote Corp.

Biote is transforming healthy aging through innovative, personalized hormone optimization therapies delivered by Biote-certified medical providers.

Sector

Healthcare

Industry

Specialized Health Services

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.